LAMB2 and metabolic dysfunction-associated steatohepatitis: It was reported that LAMs deficiency in the liver can aggravate liver inflammation and fibrosis induced by nonalcoholic steatohepatitis (NASH) in mice, indicating that LAMs can inhibit the progression of inflammation and liver fibrosis (49, 52).